Literature DB >> 16822386

Adenoidectomy and tympanostomy tubes in the management of otitis media.

Petri S Mattila1.   

Abstract

Otitis media is one of the most common childhood infections and the most frequent cause for antibiotic prescriptions in children. As respiratory infections are also associated with childhood asthma, children with recurrent otitis media or with persistent middle-ear effusion are also at an increased risk for developing asthma, which should be appreciated when a child with middle-ear disease is evaluated. The first choice of surgery in chronic middle-ear inflammatory disease is the insertion of tympanostomy tubes. It is warranted when the middle-ear effusion has lasted for 3 or more months. When chronic adenoid infection is suspected, adenoidectomy may be beneficial in treating otitis media in children who are older than 4 years of age and who have previously undergone tympanostomy-tube insertion.

Entities:  

Mesh:

Year:  2006        PMID: 16822386     DOI: 10.1007/s11882-006-0067-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  50 in total

1.  Interleukin-8 and chemotactic activity of middle ear effusions.

Authors:  M Storgaard; K Larsen; S Blegvad; H Nødgaard; T Ovesen; P L Andersen; N Obel
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

2.  A meta-analytic review of the risk factors for acute otitis media.

Authors:  M Uhari; K Mäntysaari; M Niemelä
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

3.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Authors:  S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

4.  Cow's milk allergy is associated with recurrent otitis media during childhood.

Authors:  H Juntti; S Tikkanen; J Kokkonen; O P Alho; A Niinimäki
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

5.  Human primary adenotonsillar naïve phenotype CD45RA CD4 T lymphocytes undergo apoptosis upon stimulation with a high concentration of CD3 antibody.

Authors:  M Pajusto; J Tarkkanen; P S Mattila
Journal:  Scand J Immunol       Date:  2005-12       Impact factor: 3.487

6.  Otologic facial palsy: etiology, onset, and symptom duration.

Authors:  Ellen Kvestad; Karl J Kvaerner; Iain W S Mair
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-07       Impact factor: 1.547

7.  Complications of mastoiditis in children at the onset of a new millennium.

Authors:  Yael Oestreicher-Kedem; Eyal Raveh; Liora Kornreich; Aron Popovtzer; Nora Buller; Ben Nageris
Journal:  Ann Otol Rhinol Laryngol       Date:  2005-02       Impact factor: 1.547

Review 8.  Management of lateral sinus thrombosis: update and literature review.

Authors:  Eng Hooi Ooi; Malcolm Hilton; Garrett Hunter
Journal:  J Laryngol Otol       Date:  2003-12       Impact factor: 1.469

9.  Serum interleukin-6 in bacterial and nonbacterial acute otitis media.

Authors:  T Heikkinen; F Ghaffar; A O Okorodudu; T Chonmaitree
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

10.  Plasmin and fibronectin degradation in chronic secretory otitis media.

Authors:  E M Salonen; A Vaheri; S Meri; T Lehtinen; T Palva
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-01
View more
  3 in total

1.  [Pediatric OSAS and otitis media with effusion].

Authors:  T Braun; A Dreher; F Dirr; O Reichel; M Patscheider
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

Review 2.  Role of adenoidectomy in otitis media and respiratory function.

Authors:  Petri S Mattila
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

3.  Prevalence of recurrent otitis media in habitually snoring school-aged children.

Authors:  David Gozal; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Ehab Dayyat; Ebrahim Kheirandish
Journal:  Sleep Med       Date:  2007-10-24       Impact factor: 3.492

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.